Tissue factor and tissue factor pathway inhibitor in nasal mucosa and nasal secretions of chronic rhinosinusitis with nasal polyp

American Journal of Rhinology and Allergy

Volumn 29, Issue 4, 2015, Pages 235-242

  Shimizu, Shino ^a   Ogawa, Takao ^a   Takezawa, Kumiko ^a   Tojima, Ichiro ^a   Kouzaki, Hideaki ^a   Shimizu, Takeshi ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; PROTEINASE ACTIVATED RECEPTOR; PROTEINASE ACTIVATED RECEPTOR 1 AGONIST; THROMBIN; THROMBIN ANTITHROMBIN COMPLEX; THROMBIN ANTITHROMBIN III COMPLEX; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTITHROMBIN III; ANTITHROMBIN III-PROTEASE COMPLEX; GENETIC MARKER; HEMOSTATIC AGENT; IMMUNOGLOBULIN E; LIPOPROTEIN; LIPOPROTEIN-ASSOCIATED COAGULATION INHIBITOR; MUCIN; PEPTIDE HYDROLASE;

ADULT; AGED; ALLERGIC RHINITIS; ARTICLE; ASPIRIN EXACERBATED RESPIRATORY DISEASE; ASTHMA; CELL INFILTRATION; CHRONIC RHINOSINUSITIS; CHRONIC RHINOSINUSITIS WITH NASAL POLYP; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; CORRELATIONAL STUDY; CULTURE MEDIUM; ENDOSCOPIC ENDONASAL SURGERY; EOSINOPHIL; EPITHELIUM CELL; FEMALE; FIBRIN DEPOSITION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LAMINA PROPRIA; MALE; META ANALYSIS (TOPIC); MIDDLE AGED; NASAL EPITHELIAL CELL; NOSE; NOSE MUCOSA; NOSE POLYP; NOSE SECRETION; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; TISSUE DISTRIBUTION; TURBINATE; BLOOD; CELL CULTURE; CHRONIC DISEASE; CYTOLOGY; GENETIC MARKER; GENETICS; METABOLISM; NASAL POLYPS; PATHOLOGY; PREDICTIVE VALUE; RHINITIS; SENSITIVITY AND SPECIFICITY; SINUSITIS; UPREGULATION;

ADULT; AGED; ANTITHROMBIN III; CELLS, CULTURED; CHRONIC DISEASE; EOSINOPHILS; EPITHELIAL CELLS; FEMALE; GENETIC MARKERS; HEMOSTATICS; HUMANS; IMMUNOGLOBULIN E; IMMUNOHISTOCHEMISTRY; IN VITRO TECHNIQUES; LIPOPROTEINS; MALE; MIDDLE AGED; MUCINS; NASAL MUCOSA; NASAL POLYPS; PEPTIDE HYDROLASES; PREDICTIVE VALUE OF TESTS; RHINITIS; SENSITIVITY AND SPECIFICITY; SINUSITIS; THROMBIN; THROMBOPLASTIN; UP-REGULATION;

EID: 84944060110     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2015.29.4183     Document Type: Article

References (32)

1. Pawankar R, and Nonaka M. Inflammatory mechanisms and remodeling in chronic rhinosinusitis and nasal polyps. Curr Allergy Asthma Rep 7:202-208, 2007.
2. Al-Muhsen S, Johnson JR, and Hamid Q. Remodeling in asthma. J Allergy Clin Immunol 128:451-462; quiz 463-464, 2011.
3. Shimizu S, Gabazza E, Hayashi T, et al. Thrombin stimulates the expression of PDGF in lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 279:L503-L510, 2000.
4. Shimizu S, Gabazza EC, Ogawa T, et al. Role of thrombin in chronic rhinosinusitis-associated tissue remodeling. Am J Rhinol Allergy 25: 7-11, 2011.
5. Shimizu S, Shimizu T, Morser J, et al. Role of the coagulation system in allergic inflammation in the upper airways. Clin Immunol 129: 365-371, 2008.
6. Mann K. Thrombin formation. Chest 124:4S-10S, 2003.
7. van der Poll T. Tissue factor as an initiator of coagulation and inflammation in the lung. Crit Care 12(suppl. 6):S3, 2008.
8. Matthay M, and Clements JA. Coagulation-dependent mechanisms and asthma. J Clin Invest 114:20-23, 2004.
9. Wygrecka M, Jablonska E, Guenther A, et al. Current view on alveolar coagulation and fibrinolysis in acute inflammatory and chronic interstitial lung diseases. Thromb Haemost 99:494-501, 2008.
10. So AK, Varisco PA, Kemkes-Matthes B, et al. Arthritis is linked to local and systemic activation of coagulation and fibrinolysis pathways. J Thromb Haemost 1:2510-2515, 2003.
11. Takabayashi T, Kato A, Peters AT, et al. Excessive fibrin deposition in nasal polyps caused by fibrinolytic impairment through reduction of tissue plasminogen activator expression. Am J Respir Crit Care Med 187:49-57, 2013.
12. Fokkens WJ, Lund VJ, Mullol J, et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology 50:1-12, 2012.
13. Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention. National Institutes of Health: Bethesda, MD, 2006.
14. Committee of the Practical Guideline for the Management of Allergic Rhinitis (Ed). Practical Guideline for the Management of Allergic Rhinitis in Japan. Tokyo: Life Science Publishing, 2009.
15. Greiff L, Andersson M, Erjefält J, et al. Airway microvascular extravasation and luminal entry of plasma. Clin Physiol Funct Imaging 23:301-306, 2003.
16. Wolberg AS, and Campbell RA. Thrombin generation, fibrin clot formation and hemostasis. Transfus Apher Sci 38:15-23, 2008.
17. Campbell RA, Overmyer KA, Bagnell CR, and Wolberg AS. Cellular procoagulant activity dictates clot structure and stability as a function of distance from the cell surface. Arterioscler Thromb Vasc Biol 28:2247-2254, 2008.
18. Ahmad S, Ahmad A, Rancourt RC, et al. Tissue factor signals airway epithelial basal cell survival via coagulation and protease-activated receptor isoforms 1 and 2. Am J Respir Cell Mol Biol 48:94-104, 2013.
19. Hajj R, Baranek T, Le Naour R, et al. Basal cells of the human adult airway surface epithelium retain transit-amplifying cell properties. Stem Cells 25:139-148, 2007.
20. Park JA, Sharif AS, Tschumperlin DJ, et al. Tissue factor-bearing exosome secretion from human mechanically stimulated bronchial epithelial cells in vitro and in vivo. J Allergy Clin Immunol 130:1375-1383, 2012.
21. Weber A, Köppen HO, and Schrör K. Platelet-derived microparticles stimulate coronary artery smooth muscle cell mitogenesis by a PDGF-independent mechanism. Thromb Res 98:461-466, 2000.
22. Abid Hussein MN, Meesters EW, Osmanovic N, et al. Antigenic characterization of endothelial cell-derived microparticles and their detection ex vivo. J Thromb Haemost 1:2434-2443, 2003.
23. Østerud B, and Bjørklid E. Sources of tissue factor. Semin Thromb Hemost 32:11-23, 2006.
24. Bastarache JA, Fremont RD, Kropski JA, et al. Procoagulant alveolar microparticles in the lungs of patients with acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 297:L1035-L1041, 2009.
25. Szotowski B, Antoniak S, Poller W, et al. Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines. Circ Res 96:1233-1239, 2005.
26. Adams M. Tissue factor pathway inhibitor: New insights into an old inhibitor. Semin Thromb Hemost 38:129-134, 2012.
27. Novotny WF, Girard TJ, Miletich JP, and Broze GJ Jr. Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitor. Blood 72:2020-2025, 1988.
28. Lupu C, Lupu F, Dennehy U, et al. Thrombin induces the redistribution and acute release of tissue factor pathway inhibitor from specific granules within human endothelial cells in culture. Arterioscler Thromb Vasc Biol 15:2055-2062, 1995.
29. Sugawara T, Yamabe H, Osawa H, et al. Tissue factor pathway inhibitor production by human proximal tubular epithelial cells in culture. Thromb Res 110:141-147, 2003.
30. Cugno M, Marzano AV, Tedeschi A, et al. Expression of tissue factor by eosinophils in patients with chronic urticaria. Int Arch Allergy Immunol 148:170-174, 2009.
31. Marzano AV, Tedeschi A, Berti E, et al. Activation of coagulation in bullous pemphigoid and other eosinophil-related inflammatory skin diseases. Clin Exp Immunol 165:44-50, 2011.
32. Shimizu S, Kouzaki H, Ogawa T, et al. Eosinophil-epithelial cell interactions stimulate the production of MUC5AC mucin and profibrotic cytokines involved in airway tissue remodeling. Am J Rhinol Allergy 28:103-109, 2014.